A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. (Record no. 15347152)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02182 a2200637 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514214749.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200503s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0007-0920 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/sj.bjc.6602355 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | De Placido, S |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20050330 |
| 245 00 - TITLE STATEMENT | |
| Title | A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | British journal of cancer |
| Date of publication, distribution, etc. | Feb 2005 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 467-74 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemotherapy, Adjuvant |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Combined Modality Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cyclophosphamide |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Doxorubicin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fluorouracil |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Goserelin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphatic Metastasis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Methotrexate |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tamoxifen |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | De Laurentiis, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | De Lena, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lorusso, V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Paradiso, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | D'Aprile, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pistillucci, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Farris, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sarobba, M G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Palazzo, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Manzione, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Adamo, V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Palmeri, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ferraù, F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lauria, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pagliarulo, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Petrella, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Limite, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Costanzo, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bianco, A R |
| 773 0# - HOST ITEM ENTRY | |
| Title | British journal of cancer |
| Related parts | vol. 92 |
| -- | no. 3 |
| -- | p. 467-74 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/sj.bjc.6602355">https://doi.org/10.1038/sj.bjc.6602355</a> |
| Public note | Available from publisher's website |
No items available.